Answers are grounded in this paper and cite their sources.
This review highlights recent innovations and future perspectives in the reperfusion treatment of STEMI, including radial access, bioresorbable scaffolds, and stem cell therapy.
The present article focuses on recent innovations and possible future perspectives in the reperfusion treatment of ST-segment elevation myocardial infarction (STEMI). Among these, the shift from the femoral to the radial vascular access, the recent availability of bioresorbable coronary scaffolds, other innovative forms of stent specifically designed for STEMI patients, the use of cardioprotective strategies, as well as the possibility of including autologous bone marrow stem cell transplantation as part of the treatment of patients with STEMI are described and commented on as a glance into the future.
No takes yet. Share an insight, caveat, or question.
Diletti et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: